Spectral and theoretical study of SARS-CoV-2 ORF10 protein interaction with endogenous and exogenous macroheterocyclic compounds

[Display omitted] •Molecular docking study of 3 macrocyclic compounds with QRF10 of SARS-CoV2 was shown.•Protoporphyrin and Fe(III)protoporphyrin form several types of complexes with the ORF10 protein.•The results of theoretical studies were confirmed by spectral data (UV–Vis, IR spectroscopy)•Chlor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy Molecular and biomolecular spectroscopy, 2022-10, Vol.279, p.121403, Article 121403
Hauptverfasser: Koifman, M.O., Malyasova, A.S., Romanenko, Yu.V., Yurina, E.S., Lebedeva, N.Sh, Gubarev, Yu.A., Koifman, O.I.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 121403
container_title Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
container_volume 279
creator Koifman, M.O.
Malyasova, A.S.
Romanenko, Yu.V.
Yurina, E.S.
Lebedeva, N.Sh
Gubarev, Yu.A.
Koifman, O.I.
description [Display omitted] •Molecular docking study of 3 macrocyclic compounds with QRF10 of SARS-CoV2 was shown.•Protoporphyrin and Fe(III)protoporphyrin form several types of complexes with the ORF10 protein.•The results of theoretical studies were confirmed by spectral data (UV–Vis, IR spectroscopy)•Chlorin forms with ORF10 more stable complexes than protoporphyrins. The coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 coronavirus has spread rapidly around the world in a matter of weeks. Most of the current recommendations developed for the use of antivirals in COVID-19 were developed during the initial waves of the pandemic, when resources were limited and administrative or pragmatic criteria took precedence. The choice of drugs for the treatment of COVID-19 was carried out from drugs approved for medical use. COVID-19 is a serious public health problem and the search for drugs that can relieve the disease in infected patients at various stages is still necessary. Therefore, the search for effective drugs with inhibitory and/or virucidal activity is a paramount task. Accessory proteins of the virus play a significant role in the pathogenesis of the disease, as they modulate the host's immune response. This paper studied the interaction of one of the SARS-CoV-2 accessory proteins ORF10 with macroheterocyclic compounds – protoporphyrin IX d.m.e., Fe(III)protoporphyrin d.m.e. and 5,10,15,20-tetrakis(3′-pyridyl)chlorin tetraiodide, which are potential inhibitors and virucidal agents. The SARS-CoV-2 ORF10 protein shows the highest affinity for Chlorin, which binds hydrophobically to the alpha structured region of the protein. Protoporphyrin is able to form several complexes with ORF10 close in energy, with alpha- and beta-molecular recognition features, while Fe(III)protoporphyrin forms complexes with the orientation of the porphyrin macrocycle parallel to the ORF10 alpha-helix. Taking into account the nature of the interaction with ORF10, it has been suggested that Chlorin may have virucidal activity upon photoexposure. The SARS-CoV-2 ORF10 protein was expressed in Escherichia coli cells, macroheterocyclic compounds were synthesized, and the structure was confirmed. The interaction between macrocycles with ORF10 was studied by spectral methods. The results of in silico studies were confirmed by experimental data.
doi_str_mv 10.1016/j.saa.2022.121403
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9113648</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1386142522005522</els_id><sourcerecordid>35617836</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-63f69527f14664b4f623a49e8903c872aee67cc00e09f835979681c13764ed663</originalsourceid><addsrcrecordid>eNp9kVFrFDEUhYMotlZ_gC-SPzDb3CSTySAIZbFWKBS6ra8hzdzpZtlNhiRb3Td_ulnXlvbFp-SSc77LySHkI7AZMFCnq1m2dsYZ5zPgIJl4RY5Bd6IRbdu9rnehVQOSt0fkXc4rxhhozt6SI9Eq6LRQx-T3YkJXkl1TGwZalhgTFu_qnMt22NE40sXZ9aKZxx8Np1fX58DolGJBH6gPBZN1xcdAf_qypBiGeI8hbvNfGv56nDbWpbjEKo9u59beURc3U9yGIb8nb0a7zvjh33lCbs-_3swvmsurb9_nZ5eNky2URolR9S3vRpBKyTs5Ki6s7FH3TDjdcYuoOucYQ9aPWrR91ysNDkSnJA5KiRPy5cCdtncbHByGfWozJb-xaWei9eblS_BLcx8fTA8glNQVAAdAjZJzwvHJC8zs6zArU-sw-zrMoY7q-fR86ZPj8f-r4PNBgDX6g8dksvMYHA4-1V7MEP1_8H8AYg6dCA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Spectral and theoretical study of SARS-CoV-2 ORF10 protein interaction with endogenous and exogenous macroheterocyclic compounds</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Koifman, M.O. ; Malyasova, A.S. ; Romanenko, Yu.V. ; Yurina, E.S. ; Lebedeva, N.Sh ; Gubarev, Yu.A. ; Koifman, O.I.</creator><creatorcontrib>Koifman, M.O. ; Malyasova, A.S. ; Romanenko, Yu.V. ; Yurina, E.S. ; Lebedeva, N.Sh ; Gubarev, Yu.A. ; Koifman, O.I.</creatorcontrib><description>[Display omitted] •Molecular docking study of 3 macrocyclic compounds with QRF10 of SARS-CoV2 was shown.•Protoporphyrin and Fe(III)protoporphyrin form several types of complexes with the ORF10 protein.•The results of theoretical studies were confirmed by spectral data (UV–Vis, IR spectroscopy)•Chlorin forms with ORF10 more stable complexes than protoporphyrins. The coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 coronavirus has spread rapidly around the world in a matter of weeks. Most of the current recommendations developed for the use of antivirals in COVID-19 were developed during the initial waves of the pandemic, when resources were limited and administrative or pragmatic criteria took precedence. The choice of drugs for the treatment of COVID-19 was carried out from drugs approved for medical use. COVID-19 is a serious public health problem and the search for drugs that can relieve the disease in infected patients at various stages is still necessary. Therefore, the search for effective drugs with inhibitory and/or virucidal activity is a paramount task. Accessory proteins of the virus play a significant role in the pathogenesis of the disease, as they modulate the host's immune response. This paper studied the interaction of one of the SARS-CoV-2 accessory proteins ORF10 with macroheterocyclic compounds – protoporphyrin IX d.m.e., Fe(III)protoporphyrin d.m.e. and 5,10,15,20-tetrakis(3′-pyridyl)chlorin tetraiodide, which are potential inhibitors and virucidal agents. The SARS-CoV-2 ORF10 protein shows the highest affinity for Chlorin, which binds hydrophobically to the alpha structured region of the protein. Protoporphyrin is able to form several complexes with ORF10 close in energy, with alpha- and beta-molecular recognition features, while Fe(III)protoporphyrin forms complexes with the orientation of the porphyrin macrocycle parallel to the ORF10 alpha-helix. Taking into account the nature of the interaction with ORF10, it has been suggested that Chlorin may have virucidal activity upon photoexposure. The SARS-CoV-2 ORF10 protein was expressed in Escherichia coli cells, macroheterocyclic compounds were synthesized, and the structure was confirmed. The interaction between macrocycles with ORF10 was studied by spectral methods. The results of in silico studies were confirmed by experimental data.</description><identifier>ISSN: 1386-1425</identifier><identifier>EISSN: 1873-3557</identifier><identifier>DOI: 10.1016/j.saa.2022.121403</identifier><identifier>PMID: 35617836</identifier><language>eng</language><publisher>England: Elsevier B.V</publisher><subject>Accessory proteins ; Antiviral Agents - chemistry ; Antiviral Agents - pharmacology ; Chlorin ; COVID-19 Drug Treatment ; Humans ; Models, Theoretical ; Molecular docking ; Molecular Docking Simulation ; ORF10 ; Pandemics ; Porphyrin ; Protoporphyrins ; SARS-CoV-2 ; Spectroscopy</subject><ispartof>Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2022-10, Vol.279, p.121403, Article 121403</ispartof><rights>2022 Elsevier B.V.</rights><rights>Copyright © 2022 Elsevier B.V. All rights reserved.</rights><rights>2022 Elsevier B.V. All rights reserved. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-63f69527f14664b4f623a49e8903c872aee67cc00e09f835979681c13764ed663</citedby><cites>FETCH-LOGICAL-c451t-63f69527f14664b4f623a49e8903c872aee67cc00e09f835979681c13764ed663</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1386142522005522$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35617836$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koifman, M.O.</creatorcontrib><creatorcontrib>Malyasova, A.S.</creatorcontrib><creatorcontrib>Romanenko, Yu.V.</creatorcontrib><creatorcontrib>Yurina, E.S.</creatorcontrib><creatorcontrib>Lebedeva, N.Sh</creatorcontrib><creatorcontrib>Gubarev, Yu.A.</creatorcontrib><creatorcontrib>Koifman, O.I.</creatorcontrib><title>Spectral and theoretical study of SARS-CoV-2 ORF10 protein interaction with endogenous and exogenous macroheterocyclic compounds</title><title>Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy</title><addtitle>Spectrochim Acta A Mol Biomol Spectrosc</addtitle><description>[Display omitted] •Molecular docking study of 3 macrocyclic compounds with QRF10 of SARS-CoV2 was shown.•Protoporphyrin and Fe(III)protoporphyrin form several types of complexes with the ORF10 protein.•The results of theoretical studies were confirmed by spectral data (UV–Vis, IR spectroscopy)•Chlorin forms with ORF10 more stable complexes than protoporphyrins. The coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 coronavirus has spread rapidly around the world in a matter of weeks. Most of the current recommendations developed for the use of antivirals in COVID-19 were developed during the initial waves of the pandemic, when resources were limited and administrative or pragmatic criteria took precedence. The choice of drugs for the treatment of COVID-19 was carried out from drugs approved for medical use. COVID-19 is a serious public health problem and the search for drugs that can relieve the disease in infected patients at various stages is still necessary. Therefore, the search for effective drugs with inhibitory and/or virucidal activity is a paramount task. Accessory proteins of the virus play a significant role in the pathogenesis of the disease, as they modulate the host's immune response. This paper studied the interaction of one of the SARS-CoV-2 accessory proteins ORF10 with macroheterocyclic compounds – protoporphyrin IX d.m.e., Fe(III)protoporphyrin d.m.e. and 5,10,15,20-tetrakis(3′-pyridyl)chlorin tetraiodide, which are potential inhibitors and virucidal agents. The SARS-CoV-2 ORF10 protein shows the highest affinity for Chlorin, which binds hydrophobically to the alpha structured region of the protein. Protoporphyrin is able to form several complexes with ORF10 close in energy, with alpha- and beta-molecular recognition features, while Fe(III)protoporphyrin forms complexes with the orientation of the porphyrin macrocycle parallel to the ORF10 alpha-helix. Taking into account the nature of the interaction with ORF10, it has been suggested that Chlorin may have virucidal activity upon photoexposure. The SARS-CoV-2 ORF10 protein was expressed in Escherichia coli cells, macroheterocyclic compounds were synthesized, and the structure was confirmed. The interaction between macrocycles with ORF10 was studied by spectral methods. The results of in silico studies were confirmed by experimental data.</description><subject>Accessory proteins</subject><subject>Antiviral Agents - chemistry</subject><subject>Antiviral Agents - pharmacology</subject><subject>Chlorin</subject><subject>COVID-19 Drug Treatment</subject><subject>Humans</subject><subject>Models, Theoretical</subject><subject>Molecular docking</subject><subject>Molecular Docking Simulation</subject><subject>ORF10</subject><subject>Pandemics</subject><subject>Porphyrin</subject><subject>Protoporphyrins</subject><subject>SARS-CoV-2</subject><subject>Spectroscopy</subject><issn>1386-1425</issn><issn>1873-3557</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kVFrFDEUhYMotlZ_gC-SPzDb3CSTySAIZbFWKBS6ra8hzdzpZtlNhiRb3Td_ulnXlvbFp-SSc77LySHkI7AZMFCnq1m2dsYZ5zPgIJl4RY5Bd6IRbdu9rnehVQOSt0fkXc4rxhhozt6SI9Eq6LRQx-T3YkJXkl1TGwZalhgTFu_qnMt22NE40sXZ9aKZxx8Np1fX58DolGJBH6gPBZN1xcdAf_qypBiGeI8hbvNfGv56nDbWpbjEKo9u59beURc3U9yGIb8nb0a7zvjh33lCbs-_3swvmsurb9_nZ5eNky2URolR9S3vRpBKyTs5Ki6s7FH3TDjdcYuoOucYQ9aPWrR91ysNDkSnJA5KiRPy5cCdtncbHByGfWozJb-xaWei9eblS_BLcx8fTA8glNQVAAdAjZJzwvHJC8zs6zArU-sw-zrMoY7q-fR86ZPj8f-r4PNBgDX6g8dksvMYHA4-1V7MEP1_8H8AYg6dCA</recordid><startdate>20221015</startdate><enddate>20221015</enddate><creator>Koifman, M.O.</creator><creator>Malyasova, A.S.</creator><creator>Romanenko, Yu.V.</creator><creator>Yurina, E.S.</creator><creator>Lebedeva, N.Sh</creator><creator>Gubarev, Yu.A.</creator><creator>Koifman, O.I.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20221015</creationdate><title>Spectral and theoretical study of SARS-CoV-2 ORF10 protein interaction with endogenous and exogenous macroheterocyclic compounds</title><author>Koifman, M.O. ; Malyasova, A.S. ; Romanenko, Yu.V. ; Yurina, E.S. ; Lebedeva, N.Sh ; Gubarev, Yu.A. ; Koifman, O.I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-63f69527f14664b4f623a49e8903c872aee67cc00e09f835979681c13764ed663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Accessory proteins</topic><topic>Antiviral Agents - chemistry</topic><topic>Antiviral Agents - pharmacology</topic><topic>Chlorin</topic><topic>COVID-19 Drug Treatment</topic><topic>Humans</topic><topic>Models, Theoretical</topic><topic>Molecular docking</topic><topic>Molecular Docking Simulation</topic><topic>ORF10</topic><topic>Pandemics</topic><topic>Porphyrin</topic><topic>Protoporphyrins</topic><topic>SARS-CoV-2</topic><topic>Spectroscopy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koifman, M.O.</creatorcontrib><creatorcontrib>Malyasova, A.S.</creatorcontrib><creatorcontrib>Romanenko, Yu.V.</creatorcontrib><creatorcontrib>Yurina, E.S.</creatorcontrib><creatorcontrib>Lebedeva, N.Sh</creatorcontrib><creatorcontrib>Gubarev, Yu.A.</creatorcontrib><creatorcontrib>Koifman, O.I.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koifman, M.O.</au><au>Malyasova, A.S.</au><au>Romanenko, Yu.V.</au><au>Yurina, E.S.</au><au>Lebedeva, N.Sh</au><au>Gubarev, Yu.A.</au><au>Koifman, O.I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Spectral and theoretical study of SARS-CoV-2 ORF10 protein interaction with endogenous and exogenous macroheterocyclic compounds</atitle><jtitle>Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy</jtitle><addtitle>Spectrochim Acta A Mol Biomol Spectrosc</addtitle><date>2022-10-15</date><risdate>2022</risdate><volume>279</volume><spage>121403</spage><pages>121403-</pages><artnum>121403</artnum><issn>1386-1425</issn><eissn>1873-3557</eissn><abstract>[Display omitted] •Molecular docking study of 3 macrocyclic compounds with QRF10 of SARS-CoV2 was shown.•Protoporphyrin and Fe(III)protoporphyrin form several types of complexes with the ORF10 protein.•The results of theoretical studies were confirmed by spectral data (UV–Vis, IR spectroscopy)•Chlorin forms with ORF10 more stable complexes than protoporphyrins. The coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 coronavirus has spread rapidly around the world in a matter of weeks. Most of the current recommendations developed for the use of antivirals in COVID-19 were developed during the initial waves of the pandemic, when resources were limited and administrative or pragmatic criteria took precedence. The choice of drugs for the treatment of COVID-19 was carried out from drugs approved for medical use. COVID-19 is a serious public health problem and the search for drugs that can relieve the disease in infected patients at various stages is still necessary. Therefore, the search for effective drugs with inhibitory and/or virucidal activity is a paramount task. Accessory proteins of the virus play a significant role in the pathogenesis of the disease, as they modulate the host's immune response. This paper studied the interaction of one of the SARS-CoV-2 accessory proteins ORF10 with macroheterocyclic compounds – protoporphyrin IX d.m.e., Fe(III)protoporphyrin d.m.e. and 5,10,15,20-tetrakis(3′-pyridyl)chlorin tetraiodide, which are potential inhibitors and virucidal agents. The SARS-CoV-2 ORF10 protein shows the highest affinity for Chlorin, which binds hydrophobically to the alpha structured region of the protein. Protoporphyrin is able to form several complexes with ORF10 close in energy, with alpha- and beta-molecular recognition features, while Fe(III)protoporphyrin forms complexes with the orientation of the porphyrin macrocycle parallel to the ORF10 alpha-helix. Taking into account the nature of the interaction with ORF10, it has been suggested that Chlorin may have virucidal activity upon photoexposure. The SARS-CoV-2 ORF10 protein was expressed in Escherichia coli cells, macroheterocyclic compounds were synthesized, and the structure was confirmed. The interaction between macrocycles with ORF10 was studied by spectral methods. The results of in silico studies were confirmed by experimental data.</abstract><cop>England</cop><pub>Elsevier B.V</pub><pmid>35617836</pmid><doi>10.1016/j.saa.2022.121403</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1386-1425
ispartof Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2022-10, Vol.279, p.121403, Article 121403
issn 1386-1425
1873-3557
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9113648
source MEDLINE; Elsevier ScienceDirect Journals
subjects Accessory proteins
Antiviral Agents - chemistry
Antiviral Agents - pharmacology
Chlorin
COVID-19 Drug Treatment
Humans
Models, Theoretical
Molecular docking
Molecular Docking Simulation
ORF10
Pandemics
Porphyrin
Protoporphyrins
SARS-CoV-2
Spectroscopy
title Spectral and theoretical study of SARS-CoV-2 ORF10 protein interaction with endogenous and exogenous macroheterocyclic compounds
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T01%3A54%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Spectral%20and%20theoretical%20study%20of%20SARS-CoV-2%20ORF10%20protein%20interaction%20with%20endogenous%20and%20exogenous%20macroheterocyclic%20compounds&rft.jtitle=Spectrochimica%20acta.%20Part%20A,%20Molecular%20and%20biomolecular%20spectroscopy&rft.au=Koifman,%20M.O.&rft.date=2022-10-15&rft.volume=279&rft.spage=121403&rft.pages=121403-&rft.artnum=121403&rft.issn=1386-1425&rft.eissn=1873-3557&rft_id=info:doi/10.1016/j.saa.2022.121403&rft_dat=%3Cpubmed_cross%3E35617836%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/35617836&rft_els_id=S1386142522005522&rfr_iscdi=true